Dermatology Steroids are specially designed drugs that comprise of corticosteroids that are formulated for external application on the site of interest according to requirement.
These drugs serve the primary purpose of controlling inflammation by mimicking the activity of steroid hormones that are otherwise naturally produces by the endocrine system under normal conditions. They also feature properties for immunosuppresants, vasoconstriction and reduces Cell Renewal Factor (CRF) among others.
Dermatology steroids are mostly used to address indications such as atopic dermatitis, contact dermatitis, discoid lupus erythematosus, dry skin, insect bites, intertrigo, Alopecia areata, Atopic dermatitis (resistant), Discoid lupus erythematosus, Lichen planus, Granuloma annulare etc.
Market Size and Forecast
Global Dermatology Steroids (AEDs) market is expected to flourish at a CAGR of 4.3% over the forecast period i.e. 2017-2027. Further, the market of Dermatology Steroids is expected to reach USD 4.8 Billion by the end of 2027.
Geographically Asia Pacific market is expected to grow at the highest CAGR due to rising awareness regarding preventive treatment for skin diseases in emerging economies such as China and India. Further among all Asia’s countries China has largest market share in the regional platform and is expected to continue its dominance over the forecast period. Increasing prevalence of diseases such as dermatitis, eczema etc. in these regions is expected to result in an increased demand for dermatology steroids.
Also, Europe market is expected to increase on a moderate pace due to austerity measures to cut down on public expenditures to tackle financial crisis such as the scenario in Spain. However countries such as Germany, France and Italy are expected to show increasing revenue over the forecast period. This is primarily due to encouraging government reimbursement policies to address the growing demand for dermatological products from the consumers. Request for FREE Sample copy
Further, North America dermatology steroids market is expected to grow at a substantial rate over the forecast period. Further, factors such as increased healthcare expenditure to mitigate the rising disease prevalence are expected to be the dynamic factor for the growth of dermatology steroids market in this region.
Market Segmentation
Our in-depth analysis has segmented global expandable polystyrene market into the following segments:
By Formulation
• Cream
• Gels
• Lotions
• Solutions
• Tapes
• Others
By Potency
• Very high potency
• Potent
• Upper Medium Potency
• Medium Potency
• Mild
• Least Potent
By Distribution Channel
• Retail Pharmacy
• Retail Stores
• Hospital Pharmacy
• e-Commerce
By Region
Global Dermatology Steroids market is further classified on the basis of region as follows:
• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, South Korea & Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
• Middle East and North Africa (GCC, North Africa, South Africa & Rest of Middle East) Market Size and Y-O-Y Growth Analysis
Growth Drivers & Challenges
One of the most commonly found indication for the usage of dermatology steroids are eczema. It has been observed that roughly 20% of children are affected by eczema and about 3% of the adult population suffers from the same globally. Also this is more prevalent in developing countries. This is contributing to the global disease burden due to which there have been an increasing number of pharmaceutical companies investing their resources towards developing more effective Dermatology Steroids to control the effects, minimize the incidence rates and to reduce the adverse effects of traditionally used drugs. Also, the government bodies are spending more on healthcare globally to improve the quality of life. This along with growing awareness among people towards advanced treatments is expected to positively move the market for Dermatology Steroids globally. Buy This Report
However, the increasing cost of the drugs with limited accessibility in low and middle income countries resulting in a treatment gap is expected to hamper the market growth.
Key Players
Pfizer Inc., Glaxosmithkline Plc, LEO Pharma, Teva Pharmaceuticals, Bayer, Medimetriks Pharmaceuticals, Inc., Sandoz Inc., Lupin Limited Mylan, Promius Promise etc.

About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
Ajay Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Follow us: - LinkedIn | Twitter | Facebook